New Colombia Resources Inc fka NEWC

[~S.B.A.~]

Dr. Robert J. Melamede, President of Cannabis Science was recently appointed as NEWC scientific advisor because Cannabis Science's pipeline will be doing the clinical testing in Columbia opposed to the United States.

NEWC is CBIS golden ticket in entering Columbia and being connected to Big Pharma and Universities, hence "The Company is discussing a collaborative effort with Cannabis Science, Inc"


It appears the JV/ collaborative effort between NEWC & CBIS hasn't materialized yet only talked about. Once, CBIS materializes the JV in the form of news, then i'm sure the big pharma(s) and Universities will be named.

News has only hit NEWC investor base. When and if CBIS releases a material event then their entire investor base will be alerted. With 87mil O/S, 25mil float this could run like $ENRT, & or $OSLH

" discussing clinical trials with a pharmaceutical company in Colombia for cannabis based products. These trials will be designed by a U.S. specialist so they can be used as data for eventual submission to the FDA by New Colombia or other companies"

"The venture will focus its initial efforts on a skin cancer cream and treatments for epilepsy including Dravet syndrome in children. The company will produce a high cannabinoid (CBD) strain low in tetra hydrochloride (THC) similar to the "Charlotte's Web" strain being used in Colorado. Families of children with Dravet Syndrome have been moving to Colorado to legally gain access to these strains and administer it to their children with miraculous results. New Colombia Resources will work with pharmaceutical companies to manufacture products with controlled doses like all INVIMA approved medicines"

http://finance.yahoo.com/news/colombia-resources-inc-appoints-dr-121500927.html
http://finance.yahoo.com/news/colombia-resources-inc-provides-coal-144000695.html